PUBLICATIONS · 39447094
Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2025 Feb 13
- First author
- Sehn LH
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Blood. 2025 Feb 13;145(7):655-657. doi: 10.1182/blood.2024027223.
- note
- Source null
- related pmid
- 39946154
- relationship
- Comment in
Authors and identifiers
- name
- Sehn LH
- type
- Author
- name
- Bartlett NL
- type
- Author
- name
- Matasar MJ
- type
- Author
- name
- Schuster SJ
- type
- Author
- name
- Assouline SE
- type
- Author
- name
- Giri P
- type
- Author
- name
- Kuruvilla J
- type
- Author
- name
- Shadman M
- type
- Author
- name
- Cheah CY
- type
- Author
- name
- Dietrich S
- type
- Author
- name
- Fay K
- type
- Author
- name
- Ku M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Sehn LH
- type
- Author
- name
- Bartlett NL
- type
- Author
- name
- Matasar MJ
- type
- Author
- name
- Schuster SJ
- type
- Author
- name
- Assouline SE
- type
- Author
- name
- Giri P
- type
- Author
- name
- Kuruvilla J
- type
- Author
- name
- Shadman M
- type
- Author
- name
- Cheah CY
- type
- Author
- name
- Dietrich S
- type
- Author
- name
- Fay K
- type
- Author
- name
- Ku M
- type
- Author
- bibliography ids
- nci-bib-aef56a761ffb9aa598e1300f
- book metadata
- content sha256
- 794aaaafc0bf8dcf91d50fbbadec1dc7610f2527f89d6c4f830c1097663ed51d
- document type
- citation
- dois
- 10.1182/blood.2024025454
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:39447094
- immutable id
- pubmed:39447094@794aaaafc0bf8dcf91d50fbbadec1dc7610f2527f89d6c4f830c1097663ed51d
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 7
- name
- Blood
- nlm unique id
- 7603509
- pages
- 708-719
- volume
- 145
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Blood. 2025 Feb 13;145(7):655-657. doi: 10.1182/blood.2024027223.
- note
- Source null
- related pmid
- 39946154
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 39447094
- provenance
- batch id
- 3e43afde6f26fc8df6da
- provider
- NCBI PubMed ESummary
- record sha256
- b2136f04bc98239e7c34345a693cd183afa891b0e5c9d65c18012d29de453e37
- response sha256
- fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
- retrieved at
- 2026-09-09T23:48:21.145285+00:00
- publication date
- display
- 2025 Feb 13
- precision
- day
- year
- 2025
- publication types
- Journal Article
- Clinical Trial, Phase II
- Clinical Trial, Phase I
- Multicenter Study
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle